Records containing: Metastatic Renal Cell Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-09-05A Randomized Pilot Phase II Trial of Adjuvant Immunization With G250 Peptide andThree Different Dose Levels of IL-2 Following Surgical Resection of Locally Advanced or Metastatic Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2013-07-04Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients
-
CLINICAL_TRIALS study record update · 2013-02-25Randomized Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2013-02-15Open Label, Randomized, Multicenter Phase II Study of a Combination of Torisel® (Temsirolimus) and Avastin® (Bevacizumab) Versus Sutent® (Sunitinib) and Versus a Combination of Avastin® (Bevacizumab) and Roféron® (Interferon Alpha-2a) in First-line Treatment of Patients With Metastatic Renal Cell Carcinoma.
-
CLINICAL_TRIALS study record update · 2013-01-15A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Compare the Safety and Efficacy of RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed on VEGF Receptor Tyrosine Kinase Inhibitor
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-01-04Phase II Trial of Doxorubicin and Gemcitabine in Metastatic Renal Cell Carcinoma With Sarcomatoid Features
-
CLINICAL_TRIALS study record update · 2012-08-21Non-Interventional Study In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®
-
CLINICAL_TRIALS study record update · 2012-04-19Cost Effectiveness Of Sunitinib Vs IFN-Alfa Or Bevacizumab + IFN-Alfa As First-Line Treatment In MRCC In Central America And The Caribbean
-
CLINICAL_TRIALS study record update · 2011-08-04Phase II Study of 2-Methoxyestradiol Nanocrystal Colloidal Dispersion Alone and in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma Progressing on Sunitinib Malate
-
CLINICAL_TRIALS study record update · 2011-06-17Phase II Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2010-08-24Phase II Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma Patients
-
CLINICAL_TRIALS study record update · 2010-05-26Multi-center,Middle East, Phase-II Study, Non-comparative, of the RAF-Kinase Inhibitor Sorafenib in Patients With Advanced Renal Cell Carcinoma to Evaluate The Efficacy and Tolerability of the Drug
-
CLINICAL_TRIALS study record update · 2009-09-25A Phase II, Open Label, Single Arm Study of AS1411 in Patients With Metastatic Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2009-08-25A Phase I Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2008-11-11A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients